by Richard Daverman, PhD
December 24, 2012 -- HitGen Ltd. and Viva Biotech Ltd., two China CROs specializing in early-stage services, announced a new collaboration. HitGen, located in Chengdu, offers lead generation services. VivaBiotech of Shanghai is a structure-based drug discovery CRO. According to the two companies, their now-integrated early hit-to lead generation program addresses a previously unmet need in China’s pre-clinical drug discovery sector. More details....
